SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarey Drugs & Pharmaceuticals to demerge part of petrochemical business

04 Oct 2013 Evaluate

Aarey Drugs & Pharmaceuticals has received an approval for demerger of part of petrochemical business into Enam Organics India. The board of director at its meeting held on October 03, 2013 has approved for the same. The above will however be subject to approval of Shareholder, Creditors, High Courts and other regulatory approvals.

The board of the company will remain unchanged, and the demerger will have no impact on the management structure of the company. There will also be no change in the shareholding pattern of the company.

Aarey Drugs & Pharmaceuticals is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole.

Aarey Drugs & Pharma Share Price

82.15 3.47 (4.41%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 234.90
Adani Enterprises 2218.35
Amrapali Industries 17.53
Rashi Peripheral 455.25
PDS 301.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×